First Trust Portfolios L.P. 13D and 13G filings for Tekla Life Sciences Investors:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-06 12:37 pm Purchase | 2026-02-28 | 13G | ABRDN LIFE SCIENCES INVS SH BE HQL | First Trust Portfolios L.P. | 3,021,786 10.090% | 1,194,674![]() (+65.39%) | Filing |
| 2025-04-28 09:41 am Purchase | 2025-03-31 | 13G | ABRDN LIFE SCIENCES INVS SH BE HQL | First Trust Portfolios L.P. | 1,827,112 6.330% | 1,249,420![]() (+216.28%) | Filing |
| 2023-02-06 10:39 am Sale | 2022-12-31 | 13G | ABRDN LIFE SCIENCES INVS SH BE HQL | First Trust Portfolios L.P. | 577,692 2.230% | -998,434![]() (-63.35%) | Filing |
| 2022-01-21 11:09 am Sale | 2021-12-31 | 13G | ABRDN LIFE SCIENCES INVS SH BE HQL | First Trust Portfolios L.P. | 1,576,126 6.330% | -144,560![]() (-8.40%) | Filing |

